Marty S. Springer

787 total citations
11 papers, 644 citations indexed

About

Marty S. Springer is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cell Biology. According to data from OpenAlex, Marty S. Springer has authored 11 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Cell Biology. Recurrent topics in Marty S. Springer's work include Hormonal Regulation and Hypertension (4 papers), Coenzyme Q10 studies and effects (3 papers) and Aldose Reductase and Taurine (3 papers). Marty S. Springer is often cited by papers focused on Hormonal Regulation and Hypertension (4 papers), Coenzyme Q10 studies and effects (3 papers) and Aldose Reductase and Taurine (3 papers). Marty S. Springer collaborates with scholars based in United States, Netherlands and Spain. Marty S. Springer's co-authors include Samuel D. Wright, William P. Feeney, Gail Van Riper, D. Euan MacIntyre, Roger Meurer, D. F. Hora, Patrick N. Cunningham, Hugh Rosen, Frederick Wong and Julia M. Ayala and has published in prestigious journals such as Science, The Journal of Experimental Medicine and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Marty S. Springer

11 papers receiving 618 citations

Peers

Countries citing papers authored by Marty S. Springer

Since Specialization

Citations

This map shows the geographic impact of Marty S. Springer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marty S. Springer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marty S. Springer more than expected).

Fields of papers citing papers by Marty S. Springer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marty S. Springer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marty S. Springer. The network helps show where Marty S. Springer may publish in the future.

Co-authorship network of co-authors of Marty S. Springer

This figure shows the co-authorship network connecting the top 25 collaborators of Marty S. Springer. A scholar is included among the top collaborators of Marty S. Springer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marty S. Springer. Marty S. Springer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Phenylcyclobutyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type I 2008 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Steven H. Olson, Donald W. Graham, Gool F. Patel, Anne Hermanowski‐Vosatka, Steven S. Mundt, Kashmira Shah, Marty S. Springer, Rolf Thieringer, Samuel D. Wright, Jianying Xiao, Hratch J. Zokian, Jasminka Dragovic, James M. Balkovec	38
2	Bis-aryl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1 2008 ·Bioorganic & Medicinal Chemistry Letters ·Susan D. Aster, Donald W. Graham, (unknown), Gool F. Patel, Mitree M. Ponpipom, (unknown), Michael J. Szymonifka, Steven S. Mundt, Kashmira Shah, Marty S. Springer, Rolf Thieringer, Anne Hermanowski‐Vosatka, Samuel D. Wright, Jianying Xiao, Hratch J. Zokian, James M. Balkovec	38
3	Whither or Wither Microbicides? 2008 ·Science ·Robert M. Grant, Dean H. Hamer, Thomas J. Hope, Rowena Johnston, Joep M. A. Lange, Michael M. Lederman, Judy Lieberman, Christopher J. Miller, John P. Moore, Donald E. Mosier, Douglas D. Richman, Robert T. Schooley, Marty S. Springer, Ronald S. Veazey, Mark A. Wainberg	113
4	4-Methyl-5-phenyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type I 2008 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Steven H. Olson, Anne Hermanowski‐Vosatka, Steven S. Mundt, Kashmira Shah, Marty S. Springer, Rolf Thieringer, Samuel D. Wright, Jianying Xiao, Hratch J. Zokian, James M. Balkovec	22
5	Discovery of 3,5-bis(trifluoromethyl)benzyl l-arylglycinamide based potent CCR2 antagonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·Lihu Yang, Changyou Zhou, Liangqin Guo, Gregori J. Morriello, Gabor Butora, Alexander Pasternak, William H. Parsons, Sander G. Mills, Malcolm MacCoss, Pasquale P. Vicario, Hans J. Zweerink, Julia M. Ayala, Shefali Singla, William A. Hanlon, Margaret A. Cascieri, Marty S. Springer	20
6	Discovery of 4-heteroarylbicyclo[2.2.2]octyltriazoles as potent and selective inhibitors of 11β-HSD1: Novel therapeutic agents for the treatment of metabolic syndrome 2005 ·Bioorganic & Medicinal Chemistry Letters ·Xin Gu, Jasminka Dragovic, Gloria C. Koo, Sam L. Koprak, (unknown), Steven S. Mundt, Kashmira Shah, Marty S. Springer, (unknown), Rolf Thieringer, Anne Hermanowski‐Vosatka, Hratch J. Zokian, James M. Balkovec, Sherman T. Waddell	40
7	Potent Kv1.3 inhibitors from correolide—modification of the C18 position 2004 ·Bioorganic & Medicinal Chemistry Letters ·Jianming Bao, (unknown), Frank Kayser, (unknown), Robert K. Baker, George A. Doss, John P. Felix, Randal M. Bugianesi, Robert S. Slaughter, Gregory J. Kaczorowski, María L. García, Sookhee Ha, (unknown), Gloria C. Koo, Kashmira Shah, Marty S. Springer, Mary Jo Staruch, William H. Parsons, Kathleen M. Rupprecht	18
8	Isolation and Structure of Antagonists of Chemokine Receptor (CCR5) 2004 ·Journal of Natural Products ·Hiranthi Jayasuriya, Kithsiri Herath, John G. Ondeyka, Jon D. Polishook, Gerald F. Bills, Anne W. Dombrowski, Marty S. Springer, (unknown), Lorraine Malkowitz, (unknown), Ziqiang Guan, (unknown), Dennis Stevenson, Robert P. Borris, Sheo B. Singh	73
9	Leukotriene B₄Strongly Increases Monocyte Chemoattractant Protein-1 in Human Monocytes 2004 ·Arteriosclerosis Thrombosis and Vascular Biology ·Li Huang, Annie Zhao, Frederick Wong, Julia M. Ayala, Mary Struthers, Feroze Ujjainwalla, Samuel D. Wright, Marty S. Springer, Jilly F. Evans, Jisong Cui	117
10	Benzamide derivatives as blockers of Kv1.3 ion channel 2003 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Jianming Bao, María L. García, (unknown), (unknown), Gregory J. Kaczorowski, Frank Kayser, Gloria C. Koo, (unknown), William A. Schmalhofer, Kashmira Shah, Peter M. Sinclair, Robert S. Slaughter, Marty S. Springer, Mary Jo Staruch, Nancy N. Tsou, Frederick Wong, William H. Parsons, Kathleen M. Rupprecht	25
11	Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1 alpha, or human interleukin 8. 1993 ·The Journal of Experimental Medicine ·Roger Meurer, Gail Van Riper, William P. Feeney, Patrick N. Cunningham, D. F. Hora, Marty S. Springer, D. Euan MacIntyre, Hugh Rosen	140

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact